Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Uveal Melanoma 1

Interventions

pembrolizumab 1 Melphalan 1 Ipilimumab 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Uveal Melanoma × Melphalan × Clear all

NCT02678572 2023-12-21

FOCUS

Delcath Systems Inc.

Phase 3 Completed

102 enrolled 1 FDA

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡